Clinical Trials in Los Angeles

Showing 6201-6220 of 16,901 trials

LYT-100 in Patients With BCRL

NCT04243837

This is a trial of up to 6-months duration for safety, tolerability, clinical efficacy assessments, PK and biomarkers analysis in breast carcinoma patients with secondary lymphoedema

Breast Cancer Related LymphoedemaLymphoedema

PureTech50 participantsStarted Mar 2020

Duarte, California, United States • Los Angeles, California, United States • Maitland, Florida, United States +5 more locations

COMPLETEDNA< 1 mile

The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke

NCT03805308

The primary objective of the trial is to establish the effectiveness of IAT (versus medical management) in patients with moderate-large infarcts (NCCT ASPECTS 2-5) at baseline, with adaptive enrichment to better define the upper limit of infarct volume for treatment eligibility. Furthermore, the investigators aim to determine whether certain subgroups of patients with large baseline infarcts will have a greater treatment benefit. Finally, the investigators will assess the agreement of ASPECTS scores between site investigators, the core imaging lab, and automated software.

Ischemic Stroke

Mercy Health Ohio300 participantsStarted Jul 2019

Little Rock, Arkansas, United States • Los Angeles, California, United States • Pomona, California, United States +40 more locations

LYT-100 in Patients With BCRL

The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke

Find Trials by Condition in Los Angeles

PH 1 Biomarker Study of Nivolumab and Ipilimumab and Nivolumab in Combination With Ipilimumab in Advanced Melanoma

Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology

Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures

Craniofacial Microsomia: Longitudinal Outcomes in Children Pre-Kindergarten (CLOCK)

Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years

A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)

Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

PRS-343 in HER2-Positive Solid Tumors

A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Acupuncture for PTSD

Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age

Expanded Access Protocol: Repeated Administration of Nurown® (Autologous MSC-NTF Cells) for the Treatment of ALS

Brain Oxygenation-II

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants

Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies